Nicole Villeneuve, PhD

I am currently working at Abbott Laboratories in collaboration with Reata Pharmaceuticals to help develop and characterize antioxidant inflammation modulators (AIMs), such as bardoxolone, for use in cardiovascular disease, neurodegenerative disorders and immunology.
Degree: 
PhD
Program: 
Pharmacology and Toxicology
Track: 
Pharmacology and Toxicology
Employer: 
Postdoctoral Fellow Early Discovery- Lead Discovery Technologies Chicago, IL
Dissertation Title: 
“Mechanistic Study of USP15-Dependent Deubiquitination and Characterization of Natural Compounds that Modilate the Nrf2-Keapl Antioxidant Response”
Career Type: 
Academia